Technologie de la santé
Sociétés Argentines engagées dans un secteur: technologie de la santé
Ces Sociétés Argentines opèrent dans le même secteur, technologie de la santé. Elles sont assorties de prix, de changements et d'autres statistiques pour vous aider à obtenir le plus de détails possible. La liste contient des actions pour toutes les stratégies: des géants à forte capitalisation comme ELI LILLY AND COMPANY CEDEAR EACH 56 REP 1, des sociétés à forte croissance comme MODERNA INC CEDEAR EACH 19 REP 1 ORD (USD), et bien plus encore. Filtrez la liste et vérifiez les performances des entreprises de manière pratique.
Symbole | Capitalisation boursière | Prix | Variation % | Volume | Volume Rel | P/E | BPA dil TTM | Croissance dil du BPA YoY TTM | Rendement du Dividende % TTM | Note des analystes |
|---|---|---|---|---|---|---|---|---|---|---|
 LLYELI LILLY AND COMPANY CEDEAR EACH 56 REP 1DR | 770,25 T ARS | 14 875 ARS | −1,33% | 7,49 K | 0,85 | 70,62 | 210,62 ARS | +235,69% | 0,40% | — |
| LLYDELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD) DR | 770,25 T ARS | 13,20 USD | −0,38% | 1,13 K | 0,98 | 67,24 | 210,62 ARS | +167,86% | 0,40% | — |
 JNJJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHSDR | 417,26 T ARS | 11 850 ARS | 0,00% | 17,03 K | 1,89 | 19,84 | 597,27 ARS | +206,49% | 1,77% | — |
| DJNJ3JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 417,26 T ARS | 1 300 ARS | −0,38% | 1 | 0,00 | — | — | — | — | — |
| JNJDJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS(USD) DR | 417,26 T ARS | 10,40 USD | −0,48% | 13,45 K | 6,92 | 18,68 | 597,27 ARS | +144,56% | 1,77% | — |
 ABBVABBVIE INC CEDEAR EACH 10 REPR 1 COMDR | 366,41 T ARS | 21 150 ARS | −0,12% | 221 | 0,19 | 9,42 | 2 245,57 ARS | +58,44% | 2,03% | — |
| ABBVDABBVIE INC CEDEAR EA 10 REP 1 COM(USD) DR | 366,41 T ARS | 18,55 USD | 0,00% | 8 | 0,09 | 8,86 | 2 245,57 ARS | +26,43% | 2,03% | — |
 ABTABBOTT LABORATORIES CEDEAR EACH 4 REP 1DR | 259,99 T ARS | 38 250 ARS | −1,03% | 305 | 1,00 | 20,11 | 1 901,66 ARS | +435,68% | 1,01% | — |
| ABTDABBOTT LABORATORIES CEDEAR EAC 4 REP 1(USD) DR | 259,99 T ARS | 32,70 USD | −6,57% | 22 | 0,87 | 18,45 | 1 901,66 ARS | +327,44% | 1,01% | — |
 AZNASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25DR | 245,26 T ARS | 40 625 ARS | +0,25% | 467 | 0,55 | 41,57 | 977,22 ARS | +146,53% | 1,72% | — |
| AZNDASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD) DR | 245,26 T ARS | 35,35 USD | −0,84% | 1 | 0,04 | 38,81 | 977,22 ARS | +96,72% | 1,72% | — |
 NVSNOVARTIS AG CEDEAR EACH 4 REP 1DR | 241,9 T ARS | 32 525 ARS | −0,69% | 25 | 0,18 | 4,73 | 6 872,32 ARS | +10,89% | 3,76% | — |
| NVSDNOVARTIS AG CEDEAR EAC 4 REP 1(USD) DR | 241,9 T ARS | 27,60 USD | 0,00% | 3 | 0,51 | 4,31 | 6 872,32 ARS | −11,51% | 3,76% | — |
 MRKMERCK & CO INC CEDEAR (5 REP 1 USD0.50)DR | 222,11 T ARS | 18 075 ARS | +0,98% | 3,44 K | 0,84 | 13,57 | 1 332,07 ARS | +380,66% | 2,22% | — |
| MRKDMERCK & CO INC CEDEAR EAC 5 RE 1 (USD) DR | 222,11 T ARS | 15,95 USD | +1,59% | 24 | 0,09 | 12,85 | 1 332,07 ARS | +283,54% | 2,22% | — |
 ISRGINTUITIVE SURGICAL INC CEDEAR EACH 90 REP 1 ORDDR | 221,03 T ARS | 7 060 ARS | +0,71% | 27 | 0,37 | 95,42 | 73,99 ARS | +152,31% | 0,00% | — |
 TMOTHERMO FISHER SCIENTIFIC INC CEDEAR EACH 22 REP 1DR | 171,79 T ARS | 21 175 ARS | +0,47% | 542 | 0,52 | 28,16 | 751,97 ARS | +138,83% | 0,21% | — |
| TMODTHERMO FISHER SCIENTIFIC INC CEDEAR EAC 22 REP 1(USD) DR | 171,79 T ARS | 18,75 USD | −34,21% | 259 | — | 26,75 | 751,97 ARS | +90,57% | 0,21% | — |
 AMGNAMGEN INC CEDEAR EACH 30 REP 1DR | 166,14 T ARS | 10 500 ARS | 0,00% | 547 | 0,42 | 29,54 | 355,48 ARS | +117,04% | 2,46% | — |
| AMGNDAMGEN INC CEDEAR EACH 30REPR 1 ORD USD0.0001 (USD) DR | 166,14 T ARS | 9,30 USD | 0,00% | 10 | 0,10 | 28,07 | 355,48 ARS | +73,19% | 2,46% | — |
 DHRDANAHER CORP CEDEAR EACH 54 REP 1 ORDDR | 152,47 T ARS | 4 010 ARS | +0,12% | 41 | 0,10 | 43,09 | 93,05 ARS | +88,45% | 0,25% | — |
 GILDGILEAD SCIENCES INC CEDEAR EACH 4 REP 1 COM USD0.001DR | 150,88 T ARS | 30 900 ARS | −1,67% | 829 | 0,61 | 26,84 | 1 151,42 ARS | — | 1,57% | — |
| GILDDGILEAD SCIENCES INC CEDEAR EACH 4 REP 1 SHS (USD) DR | 150,88 T ARS | 27,95 USD | 0,00% | 1 | 0,01 | 26,05 | 1 151,42 ARS | — | 1,57% | — |
 PFEPFIZER INC CEDEAR EACH 4 REP 1 ORD USD0.05DR | 148,85 T ARS | 6 680 ARS | −0,60% | 11,98 K | 0,72 | 19,62 | 340,44 ARS | +754,74% | 4,04% | — |
| PFEDPFIZER INC CEDEAR 4 REP 1 ORD USD0.05(USD) DR | 148,85 T ARS | 5,99 USD | +2,22% | 802 | 0,35 | 18,88 | 340,44 ARS | +582,03% | 4,04% | — |
 VRTXVERTEX PHARMACEUTICAL CEDEAR EACH 101 REPR 1 ORDDR | 126,66 T ARS | 5 000 ARS | −0,70% | 1,4 K | — | — | −4 208,80 ARS | −131,89% | 0,00% | — |
 MDTMEDTRONIC PLC CEDEAR EACH 4 REP 1DR | 117,92 T ARS | 23 500 ARS | −4,28% | 396 | 1,19 | 26,19 | 897,34 ARS | +157,37% | 2,01% | — |
 BMYBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1DR | 108,76 T ARS | 18 225 ARS | +0,28% | 353 | 0,28 | 21,03 | 866,77 ARS | — | 3,70% | — |
 GSKGSK PLC CEDEAR EACH REPR 1/4 ADRDR | 87,92 T ARS | 11 250 ARS | 0,00% | 473 | 0,92 | 23,67 | 475,21 ARS | +66,14% | 2,99% | — |
| GSKDGSK PLC CEDEAR EACH REPR 1/4 ADR (USD) DR | 87,92 T ARS | 9,70 USD | +1,46% | 2 | 0,02 | 21,90 | 475,21 ARS | +32,57% | 2,99% | — |
 PHGKONINKLIJKE PHILIPS NV CEDEAR EACH REPR 1/5 ADRDR | 24,42 T ARS | 5 390 ARS | −1,28% | 419 | 2,79 | — | −805,76 ARS | −134,47% | 0,00% | — |
 BIIBBIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005DR | 21,03 T ARS | 11 250 ARS | −0,66% | 115 | 0,07 | 15,23 | 738,48 ARS | +152,73% | 0,00% | — |
| BIIBDBIOGEN INC CEDEAR EAC 13 RE 1 COM(USD) DR | 21,03 T ARS | 9,46 USD | −4,92% | 7 | 0,17 | 13,74 | 738,48 ARS | +101,66% | 0,00% | — |
 MRNAMODERNA INC CEDEAR EACH 19 REP 1 ORDDR | 11,74 T ARS | 1 630 ARS | +2,52% | 92,32 K | 1,62 | — | −424,06 ARS | −37,78% | 0,00% | — |
| MRNADMODERNA INC CEDEAR EACH 19 REP 1 ORD (USD) DR | 11,74 T ARS | 1,445 USD | +3,96% | 60 | 0,03 | — | −424,06 ARS | −9,94% | 0,00% | — |
 RICHLABORATORIOS RICHMOND SACIF | 119,51 B ARS | 1 480 ARS | −0,34% | 17,32 K | 1,43 | 5,63 | 262,78 ARS | — | 0,00% | — |
 ROSEINSTITUTO ROSENBUCH SA DE BIOLOGIA | 4,13 B ARS | 97,0 ARS | −1,42% | 14,4 K | 0,83 | 22,72 | 4,27 ARS | +64,50% | 0,00% | — |